ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0939

Pilot Study: A Novel Method for Cervical Health Monitoring in African American Women with Systemic Lupus Erythematosus (SLE) Using a Self- Sampling Brush to Assess Cervical HPV Infection and Cervical Cytology

J. Patricia Dhar1, Heather Walline2, Lamia Fathallah3, Susanna Szpunar4, Louis Saravolatz5, Gil Mor6 and Thomas Carey7, 1Ascension St. John Hospital and Wayne State University School of Medicine, Bloomfield Hills, MI, 2University of Michigan, Ann Arbor, MI, 3Ascension St.John Hospital, Detroit, MI, 4Ascension St. John Hospital, Grosse Pointe Woods, MI, 5Ascension St John Hospital and Medical Center, Wayne State University School of Medicine (affiliate), Grosse Pointe Woods, MI, 6Wayne State University and C.S. Mott Center for Human Growth and Development., Detroit, MI, 7University of Michigan School of Medicine, Ann Arbor, MI

Meeting: ACR Convergence 2022

Keywords: Infection, Minority Health, prevention, Systemic lupus erythematosus (SLE), Women's health

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: A health disparity exists for AA women with SLE who have increased morbidity & mortality from both cervical cancer & SLE. Current cervical cancer screening guidelines are inadequate for these women who need frequent monitoring. We pilot tested a self-sampling brush to obtain cervical cytology & study HPV genetics to develop a less expensive & more convenient way to make cervical cancer screening more accessible for these high risk women

Methods: 30 AA women with SLE recruited from the Rheumatology clinics consented to participate in the study (IRB approved by Ascension St. John Hospital IRB). Inclusion criteria: AA women with SLE, ages 18-50 years, able to consent and obtain vaginal self sampling. Exclusion criteria: current pregnancy, & not meeting inclusion criteria. Clinical information was obtained by records review & interviewing the patient, & surveys administered to assess cervical health information, knowledge of HPV, and satisfaction with using the self sampling brush. Vaginal self sampling by the participant was performed after instruction & the brush immersed in an RNA-stable ThinPrep vial. Hologic ThinPrep automated processor was used for slide preparation & cytology read by a board-certified cytopathologist. HPV DNA &RNA were extracted, & samples were frozen at -80 0C for further analysis.

Results: All patients met established criteria for SLE: mean age =36.9 yrs., 40% had lupus nephritis, & all treated with chronic immunosuppressives [Table 1]. Two thirds had a history of abnormal pap smear ranging from atypical squamous sells of undermined significance (ASCUS) to high grade squamous intra-epithelial lesion (HSIL)/cervical intra-epithelial lesion 3 (CIN 3); 7 had a cervical biopsy & 6 underwent a surgical procedure for abnormal cytology or genital warts. HPV test results were available in 43% of which 8 were positive.Most participants had sexually transmitted diseases other than HPV, were not vaccinated for HPV, had multiple lifetime sex partners, did not smoke, & did not use condoms. The average time to last pap smear was 3.2 yrs.[Table 2] Most had knowledge that HPV can cause cervical cancer, but were unaware of HPV causing oral & genital cancers & warts. Most felt the device was easy to use, comfortable, & preferred it for over traditional pap smear. [Table 3].Cytology samples obtained from the brush showed preservation of morphology, but quality indicators were generally absent with abnormal findings in 4/30 : 3=low grade squamous intra-epithelial lesion (LSIL) and 1=ASCUS. Participants were notified of abnormal results & advised to see a gynecologist.

Conclusion: Our high risk cohort had histories of adverse cervical health, yet lacked knowledge about the spectrum of HPV related genital & oral disease & were not following health prevention strategies to reduce their risk with HPV vaccination and condoms. Cervical cytology can be performed using a brush self sampling method of collection. This study highlights the need for cervical health education, increased monitoring & intervention in these high risk women.

Supporting image 1

Table 1

Supporting image 2

Table 2

Supporting image 3

Table 3


Disclosures: J. Dhar, None; H. Walline, None; L. Fathallah, None; S. Szpunar, None; L. Saravolatz, None; G. Mor, None; T. Carey, None.

To cite this abstract in AMA style:

Dhar J, Walline H, Fathallah L, Szpunar S, Saravolatz L, Mor G, Carey T. Pilot Study: A Novel Method for Cervical Health Monitoring in African American Women with Systemic Lupus Erythematosus (SLE) Using a Self- Sampling Brush to Assess Cervical HPV Infection and Cervical Cytology [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/pilot-study-a-novel-method-for-cervical-health-monitoring-in-african-american-women-with-systemic-lupus-erythematosus-sle-using-a-self-sampling-brush-to-assess-cervical-hpv-infection-and-cervical/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pilot-study-a-novel-method-for-cervical-health-monitoring-in-african-american-women-with-systemic-lupus-erythematosus-sle-using-a-self-sampling-brush-to-assess-cervical-hpv-infection-and-cervical/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology